|
Hindustan Antibiotics Limited
Hindustan Antibiotics Limited (HAtL) is an Indian central public sector undertaking under the ownership of Ministry of Chemicals and Fertilizers, Government of India. It is based in Pune, India. It is the first government-owned-drug manufacturer in India. It was the first to launch a recombinant DNA product, rHU-Erythropoietin (Hemax) in 1993. It introduced new products like Halpen, Haltax, Hexpan in 2008. Sati-HIV drugs will be produced from September 2009.[1] History HAtL was set up in cooperation with the WHO and UNICEF with the social objective of providing affordable drugs throughout India. It was inaugurated by India's first Prime Minister Jawaharlal Nehru on 10 March 1954. Production began in 1955. It was based on Mahatma Gandhi's vision that the poor in India should get medicines at affordable rates. After reporting an operating loss in 1997 the company was reported to the Bureau of Industrial and Financial Restructuring (BIFR). On 17 January 2009 the company was taken off the books of the BIFR after reporting a record turnover of ₹ 120 crore (US$24 million). OperationsAlthough the company's primary objective was to develop drugs for the health-care industry, the company has now diversified into the agricultural and veterinary areas as well. The manufacturing plant located in Pimpri has facilities to produce bulk drugs (capacity 60 MMU annually) as well as formulations in various dosage forms – injectables (132 million vials), capsules (250 million), tablets (120 million), large volume parentrals[clarification needed] (12 million bottles annually), liquid orals, etc. In-house developed productsHealth care
Agricultural and veterinary
References
External links
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
.png)
